nedaplatin has been researched along with Carcinoma, Adenosquamous in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, A; Furukawa, N; Hirashima, Y; Itani, Y; Ito, K; Murakoshi, H; Tabata, T; Takekuma, M; Takeuchi, S; Tsubamoto, H | 1 |
| Isohashi, F; Kamiura, S; Kimura, T; Mabuchi, S; Ogawa, K; Ohta, Y; Okazawa, M; Sasano, T; Suzuki, O; Yoshioka, Y | 1 |
| Kinoshita, K; Tanaka, M; Yoshida, M | 1 |
| Hashimoto, N; Kamiura, S; Kobayashi, K; Ohira, H; Saji, F; Samejima, Y; Sawai, K; Seino, H | 1 |
| Adachi, S; Hori, Y; Koyama, K; Ogasawara, T; Oku, H; Takemura, T; Tsubamoto, H; Tsuji, Y | 1 |
3 trial(s) available for nedaplatin and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Uterine Cervical Neoplasms | 2012 |
[Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diarrhea; Drug Administration Schedule; Female; Humans; Hysterectomy; Infusions, Intravenous; Middle Aged; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms; Vomiting, Anticipatory | 2001 |
Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Survival Rate; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
2 other study(ies) available for nedaplatin and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Pelvic Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Uterine Cervical Neoplasms; Young Adult | 2013 |
[Chemotherapy using nedaplatin for advanced gynecologic cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Adenosquamous; Combined Modality Therapy; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |